Genmab | GEN - Rentabilidad Por Dividendo

Precio De Mercado
1,690.00
Cambio Diario
35.00 2.11%
Mensual
-1.34%
Anual
20.80%
Q2 Expectativa
1,628.53




Dy Cambio Fecha
Amgen 2.95 0.38 2025-12
argenx SE USD 0 0 2025-03
AstraZeneca USD 1.18 0.56 2026-03
Bayer 0.3 0.09 2025-12
Demant 0 0 2024-12
Fresenius Medical Care 3.53 0.31 2025-12
Galapagos 0 0 2025-03
Genmab 0 0 2025-03
GlaxoSmithKline 0.82 3.75 2026-03
GN Store Nord 0.97 0.19 2022-12
GRIFOLS 1.92 0.17 2025-12
Hikma Pharmaceutical USD 4.02 1.1 2025-12
Lonza 0.74 0.04 2025-12
Merck 1.8 0.22 2025-12
Novartis USD 3.33 0.29 2026-03
Regeneron Pharmaceuticals 0.46 0.01 2026-03
Roche Holding 2.96 0.8 2025-12
Sanofi 4.98 0.24 2026-03
UCB 0.58 0.25 2025-12